13th International Conference on Alzheimer's Drug Discovery
Conference - Jersey City, United States
This annual Alzheimer's Drug Discovery Foundation (ADDF) conference brings together academic and industry scientists intent on accelerating the development of innovative treatments for Alzheimer’s disease and related dementias.
The ADDF’s funded investigators and top level scientists in the field will present on their current research progress and stimulate discussion. The conference offers ample opportunities for collaboration and partnering.
Sessions include:
I. Neuroprotection: Aβ, Tau, and Mitochondria Function;
II. Neuroprotection: Synaptic Plasticity and Cognitive Enhancement;
III. ApoE and Vascular Targets;
IV. Biomarkers to Accelerate Clinical Development
(Courtesy of http://www.worldeventsforum.com/addf/addrugdiscovery/)
Mon, Sep 10, 2012 - Tue, Sep 11, 2012
Hyatt Regency Jersey City
2 Exchange Place, Jersey City, United States
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.